Morgan Stanley’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9
| Closed | -$4 | – | 8036 |
|
|
2024
Q1 | $4 | Sell |
9
-9
| -50% | -$4 | ﹤0.01% | 7793 |
|
|
2023
Q4 | $12 | Buy |
18
+9
| +100% | +$6 | ﹤0.01% | 7777 |
|
|
2023
Q3 | $8 | Buy |
9
+2
| +29% | +$2 | ﹤0.01% | 7573 |
|
|
2023
Q2 | $13 | Sell |
7
-1
| -13% | -$2 | ﹤0.01% | 7595 |
|
|
2023
Q1 | $28 | Sell |
8
-1
| -11% | -$4 | ﹤0.01% | 7627 |
|
|
2022
Q4 | $36 | Buy |
9
+1
| +13% | +$4 | ﹤0.01% | 7748 |
|
|
2022
Q3 | $0 | Sell |
8
-4
| -33% | – | ﹤0.01% | 7968 |
|
|
2022
Q2 | $0 | Sell |
12
-39
| -76% | – | ﹤0.01% | 8074 |
|
|
2022
Q1 | $2K | Sell |
51
-420
| -89% | -$16.5K | ﹤0.01% | 7778 |
|
|
2021
Q4 | $26K | Sell |
471
-2,541
| -84% | -$140K | ﹤0.01% | 7116 |
|
|
2021
Q3 | $218K | Sell |
3,012
-2,972
| -50% | -$215K | ﹤0.01% | 5958 |
|
|
2021
Q2 | $574K | Buy |
5,984
+4,772
| +394% | +$458K | ﹤0.01% | 5445 |
|
|
2021
Q1 | $180K | Buy |
1,212
+67
| +6% | +$9.95K | ﹤0.01% | 5716 |
|
|
2020
Q4 | $161K | Buy |
1,145
+561
| +96% | +$78.9K | ﹤0.01% | 5700 |
|
|
2020
Q3 | $89K | Sell |
584
-168
| -22% | -$25.6K | ﹤0.01% | 5480 |
|
|
2020
Q2 | $132K | Buy |
752
+275
| +58% | +$48.3K | ﹤0.01% | 5272 |
|
|
2020
Q1 | $68K | Buy |
477
+87
| +22% | +$12.4K | ﹤0.01% | 5349 |
|
|
2019
Q4 | $56K | Buy |
390
+15
| +4% | +$2.15K | ﹤0.01% | 5829 |
|
|
2019
Q3 | $37K | Buy |
375
+364
| +3,309% | +$35.9K | ﹤0.01% | 5834 |
|
|
2019
Q2 | $0 | Buy |
11
+1
| +10% | – | ﹤0.01% | 6792 |
|
|
2019
Q1 | $0 | Sell |
10
-2
| -17% | – | ﹤0.01% | 6754 |
|
|
2018
Q4 | $0 | Sell |
12
-2
| -14% | – | ﹤0.01% | 6778 |
|
|
2018
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 6664 |
|
|
2018
Q2 | $1K | Buy |
14
+5
| +56% | +$357 | ﹤0.01% | 6619 |
|
|
2018
Q1 | $1K | Sell |
9
-1
| -10% | -$111 | ﹤0.01% | 6564 |
|
|
2017
Q4 | $7K | Buy |
10
+1
| +11% | +$700 | ﹤0.01% | 6291 |
|
|
2017
Q3 | $3K | Sell |
9
-3
| -25% | -$1K | ﹤0.01% | 6372 |
|
|
2017
Q2 | $3K | Buy |
12
+3
| +33% | +$750 | ﹤0.01% | 6425 |
|
|
2017
Q1 | $3K | Sell |
9
-3
| -25% | -$1K | ﹤0.01% | 6431 |
|
|
2016
Q4 | $7K | Sell |
12
-2
| -14% | -$1.17K | ﹤0.01% | 6234 |
|
|
2016
Q3 | $16K | Buy |
14
+1
| +8% | +$1.14K | ﹤0.01% | 5984 |
|
|
2016
Q2 | $14K | Sell |
13
-23
| -64% | -$24.8K | ﹤0.01% | 5967 |
|
|
2016
Q1 | $47K | Sell |
36
-21
| -37% | -$27.4K | ﹤0.01% | 5632 |
|
|
2015
Q4 | $139K | Buy |
57
+7
| +14% | +$17.1K | ﹤0.01% | 5247 |
|
|
2015
Q3 | $55K | Sell |
50
-39
| -44% | -$42.9K | ﹤0.01% | 5692 |
|
|
2015
Q2 | $90K | Sell |
89
-59
| -40% | -$59.7K | ﹤0.01% | 5638 |
|
|
2015
Q1 | $150K | Buy |
148
+139
| +1,544% | +$141K | ﹤0.01% | 5344 |
|
|
2014
Q4 | $30K | Sell |
9
-3
| -25% | -$10K | ﹤0.01% | 5958 |
|
|
2014
Q3 | $35K | Sell |
12
-22
| -65% | -$64.2K | ﹤0.01% | 5835 |
|
|
2014
Q2 | $129K | Buy |
34
+3
| +10% | +$11.4K | ﹤0.01% | 5379 |
|
|
2014
Q1 | $167K | Buy |
31
+24
| +343% | +$129K | ﹤0.01% | 5200 |
|
|
2013
Q4 | $21K | Buy |
+7
| New | +$21K | ﹤0.01% | 5849 |
|